Citadel Advisors
PPBT

Citadel Advisors’s Purple Biotech PPBT Stock Holding History

Citadel Advisors’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,250
Closed -$8.22K – 13951
2025
Q4 		$8.22K Buy
+1,250
New +$9.07K ﹤0.01% 12442
2024
Q3 		– Sell
-28
Closed -$2.32K – 14997
2024
Q2 		$2.32K Sell
28
-5
-15% -$580 ﹤0.01% 13701
2024
Q1 		$4.42K Buy
33
+1
+3% +$143 ﹤0.01% 13821
2023
Q4 		$4.91K Buy
32
+8
+33% +$1.77K ﹤0.01% 13470
2023
Q3 		$5.41K Sell
24
-21
-47% -$5K ﹤0.01% 13398
2023
Q2 		$12.6K Sell
45
-138
-75% -$49.5K ﹤0.01% 13071
2023
Q1 		$64.2K Sell
183
-146
-44% -$54.7K ﹤0.01% 11839
2022
Q4 		$90.8K Sell
329
-84
-20% -$32.2K ﹤0.01% 11352
2022
Q3 		$168K Buy
413
+344
+499% +$161K ﹤0.01% 10592
2022
Q2 		$33K Sell
69
-66
-49% -$39.5K ﹤0.01% 12170
2022
Q1 		$107K Sell
135
-1
-0.7% -$645 ﹤0.01% 12224
2021
Q4 		$105K Sell
136
-1
-0.7% -$852 ﹤0.01% 12670
2021
Q3 		$124K Sell
137
-125
-48% -$121K ﹤0.01% 12610
2021
Q2 		$256K Buy
262
+197
+303% +$181K ﹤0.01% 11648
2021
Q1 		$54K Buy
+65
New +$60.7K ﹤0.01% 12871

Other funds holding PPBT

SP
SmartHarvest Portfolios Poulsbo, Washington $309M AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $4.27B AUM 45.92% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return
IA
IFG Advisory Atlanta, Georgia $2.85B AUM 26.07% 1-Year Est. Return

Citadel Advisors's PPBT Position: Q2 2026 in Review

Citadel Advisors opened a new position in Purple Biotech (PPBT) in Q2 2026: 13,166 shares worth $22.1K. The stake represents ﹤0.01% of the portfolio and ranks #13382 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in PPBT as recently as Q4 2025.

Citadel Advisors first reported a position in PPBT in Q2 2016 and has held it in 18 quarters since. The position peaked at $400K in Q2 2020. 13 funds tracked by Wall St. Rank hold PPBT as of Q2 2026.

  • Citadel Advisors held 13,166 shares of Purple Biotech worth $22.1K as of Q2 2026.
  • Purple Biotech was a new Citadel Advisors position in Q2 2026.
  • Purple Biotech made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13382 holding.
  • Citadel Advisors first reported a position in Purple Biotech in Q2 2016 and has held it in 18 quarters since.
  • Citadel Advisors's Purple Biotech position peaked at $400K in Q2 2020.
  • 13 funds tracked by Wall St. Rank held Purple Biotech as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.